Dako HercepTest To Launch Oct. 27 In Conjunction With Genentech Herceptin
This article was originally published in The Gray Sheet
Executive Summary
Market release of the Dako HercepTest will commence Oct. 27, the company said, following FDA premarket approval of the immunohistochemical anti-HER2 assay on Sept. 25.
You may also be interested in...
Iressa Lung Cancer Drug Eyed As Worthy Candidate For Companion Diagnostic
Early collaborations between drug and diagnostic firms frequently yield favorable FDA review of pharmaceutical data, speakers attested at SMI's Opportunities & Technology Trends in Global Diagnostic Testing Markets conference in London June 28-29
Iressa Lung Cancer Drug Eyed As Worthy Candidate For Companion Diagnostic
Early collaborations between drug and diagnostic firms frequently yield favorable FDA review of pharmaceutical data, speakers attested at SMI's Opportunities & Technology Trends in Global Diagnostic Testing Markets conference in London June 28-29
FDA Pharmocogenomic Data Guidance To Be Finalized By Year-End
FDA will issue a final guidance on pharmacogenomic data submissions later this year, Center for Drug Evaluation & Research Acting Director Steven Galson, MD, told the Biotechnology Industry Organization annual meeting in San Francisco